Drugs / Cytokine induced memory-like NK cells
Cytokine induced memory-like NK cells
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04354025 | Jun 2023 → Sep 2026 | acute myeloid leukemia | Washington University School of Medicine | Withdrawn | No outcome recorded |
| Phase 2 | NCT04893915 | Jun 2022 → Dec 2024 | acute myeloid leukemia, myelodysplastic syndrome | Washington University School of Medicine | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cytokine-induced memory-like NK cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04893915 ↗ |
| Modality | Cell therapy | “two infusions of cytokine-induced memory-like NK cells” NCT04893915 ↗ |